Ticker LaunchCanada to US · Cross-listing · DFTX
Definium Therapeutics, Inc.
Definium Therapeutics, Inc. (DFTX), a British Columbia-based company, cross-listed on Nasdaq on Apr 22, 2021, registering its securities on Form 8-A12B.
Definium Therapeutics, Inc., described in its filing as MindMed, is a clinical-stage biopharmaceutical company developing treatments for brain health disorders, with a focus on psychiatry, addiction, pain and neurology. It is a remote-first company.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- DFTX
- Listed
- Apr 22, 2021
- Province
- British Columbia
- Registration form
- 8-A12B
- Security
- Subordinate Voting Shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (8-A12B) Apr 22, 2021
- All filings on EDGAR CIK 1813814
Other Canadian companies listing in the US
- Vicinity Motor Corp.Nasdaq · May 13, 2021
- HIVE Blockchain Technologies Ltd.Nasdaq · May 10, 2021
- New Pacific Metals CorpNYSE American · May 4, 2021
- Largo Inc.Nasdaq · Apr 14, 2021
- Enthusiast Gaming Holdings Inc. / CanadaNasdaq · Apr 13, 2021
- Centerra Gold Inc.NYSE · Apr 12, 2021